SEC Form 4 · accession 0000899243-18-015723
T2 Biosystems, Inc. · TTOO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Alec Barclay
Officer — SVP, Operations
Period of report
Jun 6, 2018
Accepted (ET)
Jun 8, 2018 · 3:55 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001492674
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jun 6, 2018 | A | 13,583 | $0.00 | A | 15,301 | D | |
| Common Stock | Jun 6, 2018 | F | 4,408 | $8.53 | D | 10,893 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Includes 828 shares acquired under the Issuer's employee stock purchase plan on May 15, 2018.